<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bloodjour</journal-id><journal-title-group><journal-title xml:lang="ru">Гематология и трансфузиология</journal-title><trans-title-group xml:lang="en"><trans-title>Russian journal of hematology and transfusiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0234-5730</issn><issn pub-type="epub">2411-3042</issn><publisher><publisher-name>ООО Издательский дом «Практика»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18821/0234-5730-2016-61-2-100-104</article-id><article-id custom-type="elpub" pub-id-type="custom">bloodjour-48</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS OF LITERATURE</subject></subj-group></article-categories><title-group><article-title>Полиморфизм генов MICA и MICB в комплексе МНС</article-title><trans-title-group xml:lang="en"><trans-title>Major histocompatibility complex class I chain-related gene A (MICA) and B (MICB) polymorphism</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5759-0553</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зайцева Галина Алексеевна, доктор мед. наук, профессор, руководитель научного направления</p><p>610027, г. Киров</p></bio><bio xml:lang="en"><p>Zaitseva Galina A., MD, PhD, professor, head of the scientifc direction</p><p>Kirov, 610027</p></bio><email xlink:type="simple">immunlab@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1846-8237</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселева</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiseleva</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>610027, г. Киров</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3431-5273</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парамонов</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Paramonov</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>610027, г. Киров</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУН «Кировский научно-исследовательский институт гематологии и переливания крови» ФМБА России<country>Россия</country></aff><aff xml:lang="en">Kirov Research Institute of Hematology and Blood Transfusion<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>03</month><year>2019</year></pub-date><volume>61</volume><issue>2</issue><fpage>100</fpage><lpage>104</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зайцева Г.А., Киселева А.Н., Парамонов И.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Зайцева Г.А., Киселева А.Н., Парамонов И.В.</copyright-holder><copyright-holder xml:lang="en">Zaitseva G.A., Kiseleva A.N., Paramonov I.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.htjournal.ru/jour/article/view/48">https://www.htjournal.ru/jour/article/view/48</self-uri><abstract><p>Представлены данные литературы, отражающие структуру и функцию открытых в конце XX века генов локуса MIC, характеризующихся высоким полиморфизмом. Показано, что они играют важную роль в процессах межклеточного взаимодействия, участвуют в реализации реакций врожденного и адаптивного иммунитета в качестве лигандов для рецепторов NKG2D, экспрессированных на различных субпопуляциях Т-лимфоцитов. Изложены известные на сегодняшний день сведения об ассоциативной связи генов локуса MIC с заболеваниями, их влияние на исход трансплантаций. Один из разделов статьи посвящен анализу популяционных особенностей распределения аллелей MICA и MICB. Использованы 62 источника литературы, из них 3 отечественных, 47 зарубежных, представленных в следующих информационных системах: PubMed, Google Scholar, Scopus, Springer, The Cochrane Library, Wiley Online Library, РИНЦ.</p></abstract><trans-abstract xml:lang="en"><p>There are presented data of the literature about the structure and function of the opened at the end of XX century the genes of the MIC locus, characterized by high polymorphism. They play an important role in cell-cell interactions involved in the implementation of responses of the innate and adaptive immunity as ligands for the NKG2D receptors expressed on diﬀerent subpopulations of T-lymphocytes. There is relationship between MIC locus genes with diseases and their impact on the outcome of transplants. Population characteristics and distribution of MICA and MICB alleles are described.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>генетика</kwd><kwd>гены MICA и MICB</kwd><kwd>система HLA</kwd></kwd-group><kwd-group xml:lang="en"><kwd>genetics</kwd><kwd>MICA and MICB genes</kwd><kwd>HLA system</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Хаитов Р.М. Геномика HLA: новые возможности молекулярной генетики человека в диагностике и терапии. Молекулярная медицина. 2003; 1: 17–31.</mixed-citation><mixed-citation xml:lang="en">Haitov R.M. Genomic HLA: new opportunities for human molecular genetics in the diagnosis and therapy. Molecular Medicine. Russian journal (Molekulyarnaya meditsina). 2003; 1: 17–31. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Frigoul A., Lefranc M.P. MICA Standardized IMGT alleles nomenclature, polymorphisms and diseases. Recent Res. Devel. Human Genet. 2005; 3: 95–145. http://www.ld.ru/w/biometra/mica.pdf</mixed-citation><mixed-citation xml:lang="en">Frigoul A., Lefranc M.P. MICA Standardized IMGT alleles nomenclature, polymorphisms and diseases. Recent Res. Devel. Human Genet. 2005; 3: 95–145. http://www.ld.ru/w/biometra/mica.pdf</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gupta G.S. Animal lectins: form, function and clinical application. New York: Springer; 2012.</mixed-citation><mixed-citation xml:lang="en">Gupta G.S. Animal lectins: form, function and clinical application. New York: Springer; 2012.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bahram S. MIC genes: from genetics to biology. Adv. Immunol. 2001; 76: 1–60.</mixed-citation><mixed-citation xml:lang="en">Bahram S. MIC genes: from genetics to biology. Adv. Immunol. 2001; 76: 1–60.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer and in the immune response to transplants. Human Immunol. 2006; 67(3): 141–4.</mixed-citation><mixed-citation xml:lang="en">Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer and in the immune response to transplants. Human Immunol. 2006; 67(3): 141–4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Collins R.W. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur. J. Immunogenet. 2004; 31(3): 105–14.</mixed-citation><mixed-citation xml:lang="en">Collins R.W. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur. J. Immunogenet. 2004; 31(3): 105–14.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин А.А. Иммунология: учебник. М.: ГЭОТАР-Медиа; 2010.</mixed-citation><mixed-citation xml:lang="en">Yarilin A.A. Immunology: textbook. Moscow: GEOTAR-Media; 2010. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kirijas M, Spiroski M. MICA Polymorphism, Association with Diseases and Role of Anti-MICA Antibodies in Organ and Cell Transplantation. Macedonian J. Med. Sci. 2013; 6(3): 285–95.</mixed-citation><mixed-citation xml:lang="en">Kirijas M, Spiroski M. MICA Polymorphism, Association with Diseases and Role of Anti-MICA Antibodies in Organ and Cell Transplantation. Macedonian J. Med. Sci. 2013; 6(3): 285–95.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez S., Groh V., Spies T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 2006; 298: 121–38.</mixed-citation><mixed-citation xml:lang="en">Gonzalez S., Groh V., Spies T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 2006; 298: 121–38.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Janeway C.A., Travers P., Walport M., Shlomckik M. Immunobiology: the Immune System in Health and Disease. 5th ed. New York: Garland Science; 2001.</mixed-citation><mixed-citation xml:lang="en">Janeway C.A., Travers P., Walport M., Shlomckik M. Immunobiology: the Immune System in Health and Disease. 5th ed. New York: Garland Science; 2001.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Choy M.K., Phipps M.E. MICA polymorphism: biology and importance in immunity and disease. Trends Mol. Med. 2010; 16(3): 97–106. doi: 10.1016/j.molmed.2010.01.002.</mixed-citation><mixed-citation xml:lang="en">Choy M.K., Phipps M.E. MICA polymorphism: biology and importance in immunity and disease. Trends Mol. Med. 2010; 16(3): 97–106. doi: 10.1016/j.molmed.2010.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy K.M. Janeway’s Immunobiology. 8th ed. New York: Garland Science; 2011.</mixed-citation><mixed-citation xml:lang="en">Murphy K.M. Janeway’s Immunobiology. 8th ed. New York: Garland Science; 2011.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Duchmann R., Blumberg R.S., Neurath M.F., Scholmerich J., Warren Strober, Zeitz M., et al., eds. Mechanisms of Intestinal Inﬂamation: Implications for Therapeutic Inretvention in IBD. Part 1. Kluwer Academic Publishers; 2004.</mixed-citation><mixed-citation xml:lang="en">Duchmann R., Blumberg R.S., Neurath M.F., Scholmerich J., Warren Strober, Zeitz M., et al., eds. Mechanisms of Intestinal Inﬂamation: Implications for Therapeutic Inretvention in IBD. Part 1. Kluwer Academic Publishers; 2004.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hillyer C.D., Elberstein L., Ness P.M., Anderson K.C., Roback J.D. Blood banking and transfusion medicine: basic principles &amp; practice. 2nd ed. Philadelphia: Elsevier Health Sciences; 2007.</mixed-citation><mixed-citation xml:lang="en">Hillyer C.D., Elberstein L., Ness P.M., Anderson K.C., Roback J.D. Blood banking and transfusion medicine: basic principles &amp; practice. 2nd ed. Philadelphia: Elsevier Health Sciences; 2007.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cerwenka A, Lanier L.L. NK/G2D ligands: class I-like molecules exploited by viruses and cancer. Tissue Antigens. 2003; 61(5): 335–43.</mixed-citation><mixed-citation xml:lang="en">Cerwenka A, Lanier L.L. NK/G2D ligands: class I-like molecules exploited by viruses and cancer. Tissue Antigens. 2003; 61(5): 335–43.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad T., Marshall S.E., Jewell D. Genetics of inﬂammatory bowel disease: the role of HLA complex. Wld J. Gastroenterol. 2006; 12(23): 3628–35.</mixed-citation><mixed-citation xml:lang="en">Ahmad T., Marshall S.E., Jewell D. Genetics of inﬂammatory bowel disease: the role of HLA complex. Wld J. Gastroenterol. 2006; 12(23): 3628–35.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mameli A., Cauli A., Taccari E., Scarpa R., Punzi L., Lapadula G., et al. Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study. Clin. Exp. Rheumatol. 2008; 26(4): 649–52.</mixed-citation><mixed-citation xml:lang="en">Mameli A., Cauli A., Taccari E., Scarpa R., Punzi L., Lapadula G., et al. Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study. Clin. Exp. Rheumatol. 2008; 26(4): 649–52.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Romphruk A.V., Romphruk A., Choonhakarn C., Puapairoj C., Inoko H., Leelayuwat C. Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypes. Tissue Antigens. 2004; 63(6): 547–54.</mixed-citation><mixed-citation xml:lang="en">Romphruk A.V., Romphruk A., Choonhakarn C., Puapairoj C., Inoko H., Leelayuwat C. Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypes. Tissue Antigens. 2004; 63(6): 547–54.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Pollock R., Chandran V., Barrett J., Eder L., Pellett F., Yao C., et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 2011; 77(6): 554–61. doi: 10.1111/j.1399-0039.2011.01670.x.</mixed-citation><mixed-citation xml:lang="en">Pollock R., Chandran V., Barrett J., Eder L., Pellett F., Yao C., et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 2011; 77(6): 554–61. doi: 10.1111/j.1399-0039.2011.01670.x.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou X., Wang J., Zou H., Ward M.M., Weisman M.H., Espitia M.G., et al. MICA, a gene contribution strong susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 2014; 73(8): 1552–57. doi: 10/1136/annrheumdis-2013-203352.</mixed-citation><mixed-citation xml:lang="en">Zhou X., Wang J., Zou H., Ward M.M., Weisman M.H., Espitia M.G., et al. MICA, a gene contribution strong susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 2014; 73(8): 1552–57. doi: 10/1136/annrheumdis-2013-203352.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Goto K., Ota M., Maksymowych W.P., Mizuki N., Yabuki K., Katsuyama Y., et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am. J. Ophthalmol. 1998; 126(3): 436–41.</mixed-citation><mixed-citation xml:lang="en">Goto K., Ota M., Maksymowych W.P., Mizuki N., Yabuki K., Katsuyama Y., et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am. J. Ophthalmol. 1998; 126(3): 436–41.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gambelunghe G., Falorni A., Ghaderi M. Microsatellite polymorphism of the MHC class I chain – related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison’s disease. J. Clinic. Endocrinol. Metabol. 1999; 84(10): 3701–07.</mixed-citation><mixed-citation xml:lang="en">Gambelunghe G., Falorni A., Ghaderi M. Microsatellite polymorphism of the MHC class I chain – related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison’s disease. J. Clinic. Endocrinol. Metabol. 1999; 84(10): 3701–07.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen R., Metzger S., Nahir M., Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behcet’s disease in Arabs and non Ashkenazi Jews in Israil. Ann. Rheum. Dis. 2002; 61(2): 157–60.</mixed-citation><mixed-citation xml:lang="en">Cohen R., Metzger S., Nahir M., Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behcet’s disease in Arabs and non Ashkenazi Jews in Israil. Ann. Rheum. Dis. 2002; 61(2): 157–60.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gambelunghe G., Ghaderi M., Cosentino A., Falorni Ad., Brunetti P., Falorni A., Sanjeevi C.B. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia. 2000; 43(Issue 4): 507–14.</mixed-citation><mixed-citation xml:lang="en">Gambelunghe G., Ghaderi M., Cosentino A., Falorni Ad., Brunetti P., Falorni A., Sanjeevi C.B. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia. 2000; 43(Issue 4): 507–14.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Trofmov D., Sergeev I., Grudakova E., Alexeev L. The MICA alleles frequencies in healthy Russians and in type I diabetic patients. Eur. J. Immunogenet. 2002; 29(2): 147.</mixed-citation><mixed-citation xml:lang="en">Trofmov D., Sergeev I., Grudakova E., Alexeev L. The MICA alleles frequencies in healthy Russians and in type I diabetic patients. Eur. J. Immunogenet. 2002; 29(2): 147.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Nikitina-Zake L., Gupta M., Gambelunghe G., Shtauvere G., Lernmark A. Frequencies of MICA alleles signifcantly differs between Latvian, Italian and Swedish populations and are associated with type I diabetes mellitus. Tissue Antigens. 2002; 59(2): 55.</mixed-citation><mixed-citation xml:lang="en">Nikitina-Zake L., Gupta M., Gambelunghe G., Shtauvere G., Lernmark A. Frequencies of MICA alleles signifcantly differs between Latvian, Italian and Swedish populations and are associated with type I diabetes mellitus. Tissue Antigens. 2002; 59(2): 55.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Raha O., Sarkar B.N., Veerraju P., Sudhakar G., Raychaudhuri P., Mukhopadhyay S., Rao V.R. Role of MICA Repeat Polymorphism in the Manifestation of Type I Diabetes Mellitus in Bengal Indian Patients. Genetika. 2013; 45(2): 611–9. doi: 10.2298/GENSR1302611R.</mixed-citation><mixed-citation xml:lang="en">Raha O., Sarkar B.N., Veerraju P., Sudhakar G., Raychaudhuri P., Mukhopadhyay S., Rao V.R. Role of MICA Repeat Polymorphism in the Manifestation of Type I Diabetes Mellitus in Bengal Indian Patients. Genetika. 2013; 45(2): 611–9. doi: 10.2298/GENSR1302611R.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gambelunghe G., Gerli R., Bocci E.B., Sindaco P.D., Ghaderi M., Sanjeevi C.B., et al. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology. 2005; 44(3): 287–92. doi:10.1093/rheumatology/keh459.</mixed-citation><mixed-citation xml:lang="en">Gambelunghe G., Gerli R., Bocci E.B., Sindaco P.D., Ghaderi M., Sanjeevi C.B., et al. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology. 2005; 44(3): 287–92. doi:10.1093/rheumatology/keh459.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dambrauskas Z., Svensson., Joshi M., Hyltander A., Neredi P., Iresjo B. Expression of major histocompatibility complex class I-related chain AB (MICA/B) in pancreatic carcinoma. Inter. J. Oncol. 2014; 44(1): 99–104. doi: 10.3892/ijo.2013.2156.</mixed-citation><mixed-citation xml:lang="en">Dambrauskas Z., Svensson., Joshi M., Hyltander A., Neredi P., Iresjo B. Expression of major histocompatibility complex class I-related chain AB (MICA/B) in pancreatic carcinoma. Inter. J. Oncol. 2014; 44(1): 99–104. doi: 10.3892/ijo.2013.2156.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Zwirner N.W., Fuertes M.B., Girart M.V., Domaica C.I., Rossi L.E. Immunobiology of the human MHC class I chain-related gene A (MICA): from transplantation immunology to tumor immune escape. Immunologia. 2006; 25(1): 25–38.</mixed-citation><mixed-citation xml:lang="en">Zwirner N.W., Fuertes M.B., Girart M.V., Domaica C.I., Rossi L.E. Immunobiology of the human MHC class I chain-related gene A (MICA): from transplantation immunology to tumor immune escape. Immunologia. 2006; 25(1): 25–38.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Reinders J., Rozemuller E., Slootweg P., Tilanus M. The MICA-A9 allele is signifcantly decreased in Dutch HNSCC patients diagnosed with mouth cavity tumor. Tissue Antigens. 2002; 59(2): 106.</mixed-citation><mixed-citation xml:lang="en">Reinders J., Rozemuller E., Slootweg P., Tilanus M. The MICA-A9 allele is signifcantly decreased in Dutch HNSCC patients diagnosed with mouth cavity tumor. Tissue Antigens. 2002; 59(2): 106.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar V., Lo P.H., Sawai H., Kato N., Takahashi A., Deng Z., et al. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV – induced hepatocellular carcinoma. PloS One. 2012; 7(9): e44743. doi: 10.1371/journal.pone.0044743.</mixed-citation><mixed-citation xml:lang="en">Kumar V., Lo P.H., Sawai H., Kato N., Takahashi A., Deng Z., et al. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV – induced hepatocellular carcinoma. PloS One. 2012; 7(9): e44743. doi: 10.1371/journal.pone.0044743.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Luo Q.Z., Lin L., Gong Z., Mei B., Xu Y.J., Huo Z., et al. Positive association of major histocompatibility complex class I chain-related gene A polymorphism with leukemia susceptibility in the people of Han nationality of Southern China. Tissue Antigens. 2011; 78(3): 178–84.</mixed-citation><mixed-citation xml:lang="en">Luo Q.Z., Lin L., Gong Z., Mei B., Xu Y.J., Huo Z., et al. Positive association of major histocompatibility complex class I chain-related gene A polymorphism with leukemia susceptibility in the people of Han nationality of Southern China. Tissue Antigens. 2011; 78(3): 178–84.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hue S., Berrih-Aknin S., Monteiro R., Caillat-Zueman S. MICA – NKG2D interactions with in normal and pathologic thymus. Tissue Antigens. 2002; 59(2): 40.</mixed-citation><mixed-citation xml:lang="en">Hue S., Berrih-Aknin S., Monteiro R., Caillat-Zueman S. MICA – NKG2D interactions with in normal and pathologic thymus. Tissue Antigens. 2002; 59(2): 40.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kanto T., Hayashi N. Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T-cells. Hepatol. Res. 2007; 37(Suppl.3): 319–26.</mixed-citation><mixed-citation xml:lang="en">Kanto T., Hayashi N. Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T-cells. Hepatol. Res. 2007; 37(Suppl.3): 319–26.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Harapan H., Fajar J., Khalilullah S., Winardi W., Jamil K. Genetic Polymorphisms of HLA and HLA-Related Proteins Implications on Dengue Virus Infection. J. Mosquito Res. 2013; 3(1): 1–10.</mixed-citation><mixed-citation xml:lang="en">Harapan H., Fajar J., Khalilullah S., Winardi W., Jamil K. Genetic Polymorphisms of HLA and HLA-Related Proteins Implications on Dengue Virus Infection. J. Mosquito Res. 2013; 3(1): 1–10.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zdrenghea M.T., Telcian A.G., Laza-Stanca V., Bellettato C.M. RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur. Respir. J. 2012; 39(3): 712–20. doi: 10.1183/09031936.00099811.</mixed-citation><mixed-citation xml:lang="en">Zdrenghea M.T., Telcian A.G., Laza-Stanca V., Bellettato C.M. RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur. Respir. J. 2012; 39(3): 712–20. doi: 10.1183/09031936.00099811.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lazaro F.P., Werneck F.I., Mackert C., Cobat A. et al. A Major Gene Controls Leprosy Susceptibility in a Hyperendemic Isolated Population from North of Brazil. JID. 2010; 201: 1598–605.</mixed-citation><mixed-citation xml:lang="en">Lazaro F.P., Werneck F.I., Mackert C., Cobat A. et al. A Major Gene Controls Leprosy Susceptibility in a Hyperendemic Isolated Population from North of Brazil. JID. 2010; 201: 1598–605.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Fielding C.A., Aicheler R., Stanton R.J., Wang E.C.Y., Han S., Seirfan S., et al. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLOS Pathogens. 2014; 10(5): 1–17.</mixed-citation><mixed-citation xml:lang="en">Fielding C.A., Aicheler R., Stanton R.J., Wang E.C.Y., Han S., Seirfan S., et al. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLOS Pathogens. 2014; 10(5): 1–17.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Данилова А.Б., Фахрутдинова О.Л., Балдуева И.А., Моисеенко В.М. Иммунохимический анализ продукции MICA опухолевыми клетками in vitro и in vivo в контексте создания и применения противоопухолевых вакцин. Вопросы онкологии. 2010; 56(5): 576–82.</mixed-citation><mixed-citation xml:lang="en">Danilova A.B., Fakhrutdinova O.L., Baldueva I.A., Moiseenko V.M. Immunochemical assay of MICA production by tumor cells in vitro and in vivo as a component of antitumor vaccine development. Problems in Oncology. Russian journal (Voprosy onkologii). 2010; 56(5): 576–82. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nat. Immunol. 2002; 419(6908): 734–8.</mixed-citation><mixed-citation xml:lang="en">Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nat. Immunol. 2002; 419(6908): 734–8.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Boukouaci W., Busson M., Peffault de Latour R., Rocha V., Suberbielle C., Bengoufa D., et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versushost disease. Blood. 2009; 114(25): 5216–24.</mixed-citation><mixed-citation xml:lang="en">Boukouaci W., Busson M., Peffault de Latour R., Rocha V., Suberbielle C., Bengoufa D., et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versushost disease. Blood. 2009; 114(25): 5216–24.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Абакушина Е.В., Кузьмина Е.Г. Стрессиндуцированные молекулы MICA/B И их роль в развитии онкологических заболеваний. Молекулярная медицина. 2012; 4: 16–20.</mixed-citation><mixed-citation xml:lang="en">Abakushina E.V., Kuzmina E.G. Stress-induced molecules MICA/B and their role in cancer development. Molecular Medicine. Russian journal (Molekulyarnaya meditsina). 2012; 4: 16–20. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Mincheva-Nilsson L., Nagaeva O., Chen T., Stendahl U., Antsiferova J., Mogren I., et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J. Immunol. 2006; 176(6): 3585–92. doi:10.4049/jimmunol.176.6.3289.</mixed-citation><mixed-citation xml:lang="en">Mincheva-Nilsson L., Nagaeva O., Chen T., Stendahl U., Antsiferova J., Mogren I., et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J. Immunol. 2006; 176(6): 3585–92. doi:10.4049/jimmunol.176.6.3289.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Tait B.D., Susal C., Gebel H.M., Nickerson P.W., Zachary A.A., Claas F.N., et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013; 95(1): 19–47.</mixed-citation><mixed-citation xml:lang="en">Tait B.D., Susal C., Gebel H.M., Nickerson P.W., Zachary A.A., Claas F.N., et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013; 95(1): 19–47.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Narayan S., Tsai E.W., Zhang O., Wallace W.D., Reed E.F., Ettenger R.B. Acute rejection associated with donor-specifc anti-MICA antibody in highly sensitized pediatric renal transplant recipient. Pediatric Transpl. 2011; 15(1): 1–7.</mixed-citation><mixed-citation xml:lang="en">Narayan S., Tsai E.W., Zhang O., Wallace W.D., Reed E.F., Ettenger R.B. Acute rejection associated with donor-specifc anti-MICA antibody in highly sensitized pediatric renal transplant recipient. Pediatric Transpl. 2011; 15(1): 1–7.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Terasaki P.I., Ozawa M., Castro R. Four year follow-up of a prospective trial of HLA and MICA antibodies of Kidney graft survival. Am. J. Transpl. 2007; 7(2): 408–15.</mixed-citation><mixed-citation xml:lang="en">Terasaki P.I., Ozawa M., Castro R. Four year follow-up of a prospective trial of HLA and MICA antibodies of Kidney graft survival. Am. J. Transpl. 2007; 7(2): 408–15.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Parmar S., DeLima M., Zou Y., Patah P.A., Liu P., Cano P., et al. Donor – recipient mismatches in MHC class I chain – related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versushost disease. Blood. 2009; 114(14): 2884–7.</mixed-citation><mixed-citation xml:lang="en">Parmar S., DeLima M., Zou Y., Patah P.A., Liu P., Cano P., et al. Donor – recipient mismatches in MHC class I chain – related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versushost disease. Blood. 2009; 114(14): 2884–7.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y., Zhang M., Lavingia B. Allontibodies against MICA alleles in sera from kidney transplant patients react with the alfa-2 domain of MICA antigens. Tissue Antigens. 2002; 59(Suppl.2): 42.</mixed-citation><mixed-citation xml:lang="en">Zou Y., Zhang M., Lavingia B. Allontibodies against MICA alleles in sera from kidney transplant patients react with the alfa-2 domain of MICA antigens. Tissue Antigens. 2002; 59(Suppl.2): 42.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y., Statny P., Susal C. Antibodies against MICA antigens and kidneytransplant rejection. N. Engl. J. Med. 2007; 357(13): 1293–1300.</mixed-citation><mixed-citation xml:lang="en">Zou Y., Statny P., Susal C. Antibodies against MICA antigens and kidneytransplant rejection. N. Engl. J. Med. 2007; 357(13): 1293–1300.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M., Lu F., Qu L., He J., Yuan X.N., Gu Y. Serum major-histocompatibility–complex class I–related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients. Chin. Med. J. 2011; 124(14): 2127–31.</mixed-citation><mixed-citation xml:lang="en">Zhang M., Lu F., Qu L., He J., Yuan X.N., Gu Y. Serum major-histocompatibility–complex class I–related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients. Chin. Med. J. 2011; 124(14): 2127–31.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ozawa M., Rebellato L.M., Terasaki P., Tong A., Briley K.P., Catrou P., et al. Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience. Clin. Transpl. 2006: 265–90.</mixed-citation><mixed-citation xml:lang="en">Ozawa M., Rebellato L.M., Terasaki P., Tong A., Briley K.P., Catrou P., et al. Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience. Clin. Transpl. 2006: 265–90.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Lemy A., Andrien M., Lionet A., Laballete M., Noel C., Hiesse C. Posttransplant major histocompatibility complex Class I chain-related gene A antibodies and long-term graft outcomes in a Multicenter Cohort of 779 Kidney Transplant. Transplantation. 2012; 93(12): 1258-64.</mixed-citation><mixed-citation xml:lang="en">Lemy A., Andrien M., Lionet A., Laballete M., Noel C., Hiesse C. Posttransplant major histocompatibility complex Class I chain-related gene A antibodies and long-term graft outcomes in a Multicenter Cohort of 779 Kidney Transplant. Transplantation. 2012; 93(12): 1258-64.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Suarez-Alvarez B., Lopez-Vazguez A., Gonzalez M.Z., Fdez-Morera J.L., Diaz-Molina B., Blanco-Gelaz M.A., et al. The relationship of antiMICA antibodies and MICA expression with heart allograft rejection. Am. J. Transplant. 2007; 7(7): 1842–8.</mixed-citation><mixed-citation xml:lang="en">Suarez-Alvarez B., Lopez-Vazguez A., Gonzalez M.Z., Fdez-Morera J.L., Diaz-Molina B., Blanco-Gelaz M.A., et al. The relationship of antiMICA antibodies and MICA expression with heart allograft rejection. Am. J. Transplant. 2007; 7(7): 1842–8.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Kauke T., Kaszmarek L., Dick A., Schomoeckel M., Deutsch M.A., Beiras-Fernandez A., et al. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients. J. Transplant. 2009; 28(4): 305–11.</mixed-citation><mixed-citation xml:lang="en">Kauke T., Kaszmarek L., Dick A., Schomoeckel M., Deutsch M.A., Beiras-Fernandez A., et al. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients. J. Transplant. 2009; 28(4): 305–11.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Smith J.D., Brunner V.M., Jigjidsuren S., Hamour I.M. Lack of effect of MICA antibodies on graft survival following heart transplantation. Am. J. Transplant. 2009; 9(8): 1912–9. doi: 10.1111/j.1600-6143.2009.02722.x.</mixed-citation><mixed-citation xml:lang="en">Smith J.D., Brunner V.M., Jigjidsuren S., Hamour I.M. Lack of effect of MICA antibodies on graft survival following heart transplantation. Am. J. Transplant. 2009; 9(8): 1912–9. doi: 10.1111/j.1600-6143.2009.02722.x.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Sohn Y.H., Cha C.H., Oh H.B., Kim M.H., Choi S.E., Kwon O.J. MICA polymorphisms and haplotypes with HLA-B and HLA-DRB1* in Koreans. Tissue Antigens. 2010; 75(1): 48–55.</mixed-citation><mixed-citation xml:lang="en">Sohn Y.H., Cha C.H., Oh H.B., Kim M.H., Choi S.E., Kwon O.J. MICA polymorphisms and haplotypes with HLA-B and HLA-DRB1* in Koreans. Tissue Antigens. 2010; 75(1): 48–55.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Vavilov M.N., Suslova T.A., Burmistrova A.L., Darke C. HLA and MICB alleles in ancestral haplotypes in Russian and Bashkir populations of the Chelyabinsk Region of Russian South Urals. Tissue Antigens. 2012; 79(6): 531.</mixed-citation><mixed-citation xml:lang="en">Vavilov M.N., Suslova T.A., Burmistrova A.L., Darke C. HLA and MICB alleles in ancestral haplotypes in Russian and Bashkir populations of the Chelyabinsk Region of Russian South Urals. Tissue Antigens. 2012; 79(6): 531.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Suslova T.A., Burmistrova A.L., Chernova M.S., Khromova E.B., Lupar E., et al. HLA-gene and haplotype frequencies in Bashkirs, Russian and Tatars, living in the Chelyabinsk regions (Russian South Urals). Inter. J. Immunogenet. 2012; 39(5): 394–408. doi: 10.1111/j.1744-313X.2012.01117.x.</mixed-citation><mixed-citation xml:lang="en">Suslova T.A., Burmistrova A.L., Chernova M.S., Khromova E.B., Lupar E., et al. HLA-gene and haplotype frequencies in Bashkirs, Russian and Tatars, living in the Chelyabinsk regions (Russian South Urals). Inter. J. Immunogenet. 2012; 39(5): 394–408. doi: 10.1111/j.1744-313X.2012.01117.x.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y., Stastny P. Screening for antibodies against MICA by luminex ﬂow cytometry. Methods Mol. Biol. 2012; 882: 279–88. doi: 10.1007/978-1-61779-842-9_16.</mixed-citation><mixed-citation xml:lang="en">Zou Y., Stastny P. Screening for antibodies against MICA by luminex ﬂow cytometry. Methods Mol. Biol. 2012; 882: 279–88. doi: 10.1007/978-1-61779-842-9_16.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang X., Huang J.F., Huo Z., Zhang Q., Jiang Y., Wu X., et al. Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients. BMC Immunol. 2012; 13: 62. doi: 10.1186/1471-2172-13-62. http://www.biomedcentral.com/1471-2172/13/62</mixed-citation><mixed-citation xml:lang="en">Jiang X., Huang J.F., Huo Z., Zhang Q., Jiang Y., Wu X., et al. Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients. BMC Immunol. 2012; 13: 62. doi: 10.1186/1471-2172-13-62. http://www.biomedcentral.com/1471-2172/13/62</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y., Mirbaha F., Lazaro A., Zhanq I., Lavingia B., Stastny P. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum. Immunol. 2002; 63(1): 30–9.</mixed-citation><mixed-citation xml:lang="en">Zou Y., Mirbaha F., Lazaro A., Zhanq I., Lavingia B., Stastny P. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum. Immunol. 2002; 63(1): 30–9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
